CDRH Device Expedited Access Program Set For April 15 Launch, Extended To De Novos
This article was originally published in The Pink Sheet Daily
Executive Summary
The program primarily targets PMA devices, but those that use the de novo classification route are also eligible for a watered-down version for the program. 510(k)s are not eligible for the program.
You may also be interested in...
FDA’s Expedited PMA Pathway Proposal: To Expand Or Contain?
Companies want FDA to expand the bounds of its accelerated device development program, while others urge FDA to be cautious.
FDA Eyes Upclassification, Labeling Guidance To Address Stapler Risks
The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.
Device Week, March 8, 2019 – Scott Gottlieb Resigns
On the latest Medtech Insight podcast, David Filmore and Ferdous Al-Faruque discuss the unexpected news that Scott Gottlieb is leaving US FDA next month. What has been his legacy for medtech, and who will replace him?